
Talking HPV Episode 2 Part 1 -HPV Cancer Types, Research & Treatments
The Marie Keating Foundation "Talks Cancer" PodcastShow Notes
In the second episode of Talking HPV we had so much information that we split this incredible episode into Part 1 and 2.
We were privileged to be joined by some incredibly knowledgeable guests for our round table discussion on HPV Cancer Types, Research & Treatments
In this episode we have Bernie Carter – Assistant Director of Nursing at the Marie Keating Foundation, Associate Professor in Molecular Pathology Dr. Cara Martin, Patient representatives Lyn Fenton and Kim Hanly
We delve further into HPV discussing topics such as
• What cancer types are caused by HPV?
• Are people born female more at risk?
• Are there effective treatments for HPV?
• Being diagnosed with cervical cancer, impact on patient and family?
Along with hearing about the lived experience of women diagnosed with Cervical cancer.
Listen in and subscribe on Spotify, apple podcasts or wherever you listen to your podcasts.
Visit www.mariekeating.ie for a host of up-to-date information and resources on HPV, Cervical Cancer and Mouth Head and Neck Cancer.
More from The Marie Keating Foundation "Talks Cancer" Podcast
In this episode of #TalkingHPV we continue our conversation with Bernie Carter – Assistant Director of Nursing at the Marie Keating Foundation, Associate Professor in Molecular Pathology Dr. Cara Martin, Patient representatives Lyn Fenton and Kim Hanly.
In this episode Director of Nursing Services at the Marie Keating Foundation Helen Forristal and Assistant Director of Nursing Bernie Carter kick off this series by exploring the facts around HPV in Ireland. They clear up misconceptions and answer questions such as:
Episode 4 part 2 is a continuation of the important conversations started in Part 1.
We have reached the final episode of this series of the Marie Keating Foundation Talks Cancer podcast. There is so much valuable information in this episode that we have made it a 2 Parter!
Discussion with women living with Metastatic Breast Cancer